LANA ROYER: Open Payments
NPI 1750953360 · UNIONTOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 36 payments from 10 companies in 2025. Trend: 2023 $122 · 2024 $597 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $170 |
| Vanda Pharmaceuticals Inc. | 5 | $134 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| Neurocrine BioSciences, Inc. | 3 | $64 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Teva Pharmaceuticals USA, Inc. | 3 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| ABBVIE INC. | 2 | $33 |
| Braeburn Inc. | 2 | $31 |
| Luye Pharma (USA) Ltd. | 1 | $23 |
Products named: ARISTADA, FANAPT, CAPLYTA, INGREZZA, Auvelity, UZEDY, BRIXADI, SPRAVATO.
Industry payments across OH — which companies pay providers there.
